Enrolled February 22, 2023 Passed IN Senate February 17, 2023 CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION Senate Resolution No. 14Introduced by Senator BeckerFebruary 07, 2023 Relative to hypertrophic cardiomyopathy. LEGISLATIVE COUNSEL'S DIGESTSR 14, Becker. Digest KeyBill TextWHEREAS, Hypertrophic cardiomyopathy (HCM) is a chronic cardiovascular disease involving thickening of the heart muscle and can potentially lead to debilitating symptoms and serious complications, including heart failure, atrial fibrillation, stroke, and in rare cases sudden cardiac death; andWHEREAS, HCM is the most common inheritable heart disease and can affect anyone regardless of age, gender, or ethnicity with a reported prevalence ranging from 1 in 200 to 1 in 500 in the general population; andWHEREAS, An estimated 700,000 people in the United States have HCM, yet 85 percent of them may remain undiagnosed; andWHEREAS, HCM shares symptoms with other common cardiovascular and pulmonary diseases, such as shortness of breath, chest pain, fatigue, palpitations, and fainting, making it difficult to distinguish HCM from these other diseases; andWHEREAS, All-cause mortality risk is three to four times higher in patients with HCM than that of the general population; andWHEREAS, Knowing ones medical history and any signs and symptoms of HCM is an important first step in receiving an accurate diagnosis of HCM; andWHEREAS, A health care provider must conduct a thorough screening with cardiac health questions to help identify a risk of cardiac disorders both genetic and congenital; andWHEREAS, A health care provider may conduct several tests, including an echocardiogram, a cardiac MRI, or genetic testing to confirm a family history of HCM, and must examine the heart to diagnose HCM; andWHEREAS, Following a diagnosis of HCM, it is important for patients to work with their health care provider to learn more about their disease and understand different management options, including prescription medicines and surgical treatment options that may help; andWHEREAS, The fourth Wednesday in February is an appropriate day to observe Hypertrophic Cardiomyopathy Awareness Day; now, therefore, be itResolved by the Senate of the State of California, That the fourth Wednesday in February of each year is designated as Hypertrophic Cardiomyopathy Awareness Day in the State of California in order to raise public awareness about hypertrophic cardiomyopathy; and be it furtherResolved, That the Senate acknowledges the critical importance of hypertrophic cardiomyopathy awareness to improve cardiovascular health in the State of California; and be it further Resolved, That the Senate supports raising awareness of the consequences of undiagnosed and untreated hypertrophic cardiomyopathy and the need to seek appropriate care for hypertrophic cardiomyopathy as a serious public health issue; and be it furtherResolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.
Enrolled February 22, 2023 Passed IN Senate February 17, 2023 CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION Senate Resolution No. 14Introduced by Senator BeckerFebruary 07, 2023 Relative to hypertrophic cardiomyopathy. LEGISLATIVE COUNSEL'S DIGESTSR 14, Becker. Digest Key
Enrolled February 22, 2023 Passed IN Senate February 17, 2023
Enrolled February 22, 2023
Passed IN Senate February 17, 2023
CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION
Senate Resolution
No. 14
Introduced by Senator BeckerFebruary 07, 2023
Introduced by Senator Becker
February 07, 2023
Relative to hypertrophic cardiomyopathy.
LEGISLATIVE COUNSEL'S DIGEST
## LEGISLATIVE COUNSEL'S DIGEST
SR 14, Becker.
## Digest Key
## Bill Text
WHEREAS, Hypertrophic cardiomyopathy (HCM) is a chronic cardiovascular disease involving thickening of the heart muscle and can potentially lead to debilitating symptoms and serious complications, including heart failure, atrial fibrillation, stroke, and in rare cases sudden cardiac death; and
WHEREAS, HCM is the most common inheritable heart disease and can affect anyone regardless of age, gender, or ethnicity with a reported prevalence ranging from 1 in 200 to 1 in 500 in the general population; and
WHEREAS, An estimated 700,000 people in the United States have HCM, yet 85 percent of them may remain undiagnosed; and
WHEREAS, HCM shares symptoms with other common cardiovascular and pulmonary diseases, such as shortness of breath, chest pain, fatigue, palpitations, and fainting, making it difficult to distinguish HCM from these other diseases; and
WHEREAS, All-cause mortality risk is three to four times higher in patients with HCM than that of the general population; and
WHEREAS, Knowing ones medical history and any signs and symptoms of HCM is an important first step in receiving an accurate diagnosis of HCM; and
WHEREAS, A health care provider must conduct a thorough screening with cardiac health questions to help identify a risk of cardiac disorders both genetic and congenital; and
WHEREAS, A health care provider may conduct several tests, including an echocardiogram, a cardiac MRI, or genetic testing to confirm a family history of HCM, and must examine the heart to diagnose HCM; and
WHEREAS, Following a diagnosis of HCM, it is important for patients to work with their health care provider to learn more about their disease and understand different management options, including prescription medicines and surgical treatment options that may help; and
WHEREAS, The fourth Wednesday in February is an appropriate day to observe Hypertrophic Cardiomyopathy Awareness Day; now, therefore, be it
Resolved by the Senate of the State of California, That the fourth Wednesday in February of each year is designated as Hypertrophic Cardiomyopathy Awareness Day in the State of California in order to raise public awareness about hypertrophic cardiomyopathy; and be it further
Resolved, That the Senate acknowledges the critical importance of hypertrophic cardiomyopathy awareness to improve cardiovascular health in the State of California; and be it further
Resolved, That the Senate supports raising awareness of the consequences of undiagnosed and untreated hypertrophic cardiomyopathy and the need to seek appropriate care for hypertrophic cardiomyopathy as a serious public health issue; and be it further
Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.